MORE►
FEATURED
[Image: Foryou13/istockphoto]
Patented: Island Technology’s Kernel-Based Protection of Computer Processes and More North Texas Inventive Activity
by Dallas Innovates | Staff Report | Dec 17, 2025
Dallas-Fort Worth ranked No. 10 for patent activity out of 250 metros for the week of Nov. 11 with a total of 128 patents granted.
by Quincy Preston |
Dec 17, 2025
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
MORE►
by Sandra Engelland |
Dec 16, 2025
Competing against four global startups at Smart City Expo World Congress in Barcelona, Omniflow won funding, travel, piloting, and business development opportunities in the United States, along with the NTXIA Champion Texas Belt Buckle.
MORE►
Reports: Texas Stock Exchange Settles Trademark Dispute Over ‘TXSE’ as Backing Grows to $270 Million
by Quincy Preston |
Dec 16, 2025
The Dallas-based Texas Stock Exchange has resolved a trademark dispute with the Toronto Stock Exchange over its “TXSE” branding, The Texas Lawbook reported. Separately, Bloomberg reported that total funding for TXSE Group, the exchange’s parent company, has reached $270 million with new backing from Goldman and Bank of America.
MORE►
[Image: lukpedclub_istockphoto]
Calendar: Not-to-Miss Events for Innovators in Dallas-Fort Worth
by Dallas Innovates | Staff Report | Dec 16, 2025
North Texas has plenty to see, hear, and watch. Here are our editors' picks. Plus, you'll find more selections to "save the date."
MORE►
by Dallas Innovates | Staff Report |
Dec 12, 2025
You'll find deadlines coming up for a new accelerator program; and many more opportunities.
MORE►
by Sandra Engelland |
Dec 11, 2025
The 25-year-old Irving-based pop culture merchandising powerhouse tapped serial entrepreneur Matt Alexander to lead its new venture fund backing early-stage consumer brands.
MORE►
by Sandra Engelland |
Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE►
